Subpart B. Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin
- § 201.50 - Statement of identity.
- § 201.51 - Declaration of net quantity of contents.
- § 201.55 - Statement of dosage.
- § 201.56 - Requirements on content and format of labeling for human prescription drug and biological products.
- § 201.57 - Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1).
- § 201.58 - Waiver of labeling requirements.